Gene suppression approaches to neurodegeneration

Abstract Gene suppression approaches have emerged over the last 20 years as a novel therapeutic approach for the treatment of neurodegenerative diseases. These include RNA interference and anti-sense oligonucleotides, both of which act at the post-transcriptional level, and genome-editing techniques...

Full description

Bibliographic Details
Main Authors: Rhia Ghosh, Sarah J. Tabrizi
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13195-017-0307-1
id doaj-7f6bbf8b607e4b7d830ae17ed046150c
record_format Article
spelling doaj-7f6bbf8b607e4b7d830ae17ed046150c2020-11-25T00:48:54ZengBMCAlzheimer’s Research & Therapy1758-91932017-10-019111310.1186/s13195-017-0307-1Gene suppression approaches to neurodegenerationRhia Ghosh0Sarah J. Tabrizi1UCL Huntington’s Disease Centre, Department of Neurodegenerative Disease, UCL Institute of NeurologyUCL Huntington’s Disease Centre, Department of Neurodegenerative Disease, UCL Institute of NeurologyAbstract Gene suppression approaches have emerged over the last 20 years as a novel therapeutic approach for the treatment of neurodegenerative diseases. These include RNA interference and anti-sense oligonucleotides, both of which act at the post-transcriptional level, and genome-editing techniques, which aim to repair the responsible mutant gene. All serve to inhibit the expression of disease-causing proteins, leading to the potential prevention or even reversal of the disease phenotype. In this review we summarise the main developments in gene suppression strategies, using examples from Huntington’s disease and other inherited causes of neurodegeneration, and explore how these might illuminate a path to tackle other proteinopathy-associated dementias in the future.http://link.springer.com/article/10.1186/s13195-017-0307-1Gene suppressionRNA interferenceAnti-sense oligonucleotidesZinc-finger proteinsCRISPR/Cas9Therapeutics
collection DOAJ
language English
format Article
sources DOAJ
author Rhia Ghosh
Sarah J. Tabrizi
spellingShingle Rhia Ghosh
Sarah J. Tabrizi
Gene suppression approaches to neurodegeneration
Alzheimer’s Research & Therapy
Gene suppression
RNA interference
Anti-sense oligonucleotides
Zinc-finger proteins
CRISPR/Cas9
Therapeutics
author_facet Rhia Ghosh
Sarah J. Tabrizi
author_sort Rhia Ghosh
title Gene suppression approaches to neurodegeneration
title_short Gene suppression approaches to neurodegeneration
title_full Gene suppression approaches to neurodegeneration
title_fullStr Gene suppression approaches to neurodegeneration
title_full_unstemmed Gene suppression approaches to neurodegeneration
title_sort gene suppression approaches to neurodegeneration
publisher BMC
series Alzheimer’s Research & Therapy
issn 1758-9193
publishDate 2017-10-01
description Abstract Gene suppression approaches have emerged over the last 20 years as a novel therapeutic approach for the treatment of neurodegenerative diseases. These include RNA interference and anti-sense oligonucleotides, both of which act at the post-transcriptional level, and genome-editing techniques, which aim to repair the responsible mutant gene. All serve to inhibit the expression of disease-causing proteins, leading to the potential prevention or even reversal of the disease phenotype. In this review we summarise the main developments in gene suppression strategies, using examples from Huntington’s disease and other inherited causes of neurodegeneration, and explore how these might illuminate a path to tackle other proteinopathy-associated dementias in the future.
topic Gene suppression
RNA interference
Anti-sense oligonucleotides
Zinc-finger proteins
CRISPR/Cas9
Therapeutics
url http://link.springer.com/article/10.1186/s13195-017-0307-1
work_keys_str_mv AT rhiaghosh genesuppressionapproachestoneurodegeneration
AT sarahjtabrizi genesuppressionapproachestoneurodegeneration
_version_ 1725254337185185792